ALI HEALTH Reveals New Board Line-up and Committee Leadership Effective 29 July 2026

Bulletin Express07-29

ALI HEALTH (Alibaba Health Information Technology Limited) released an update on its corporate governance structure, confirming board and committee appointments that take effect on 29 July 2026.

The reconstituted Board will comprise six members: • Executive Directors: Mr. Shen Difan (Chairman and Chief Executive Officer) and Ms. Sheng Mengyue • Non-executive Director: Ms. Huang Jiaojiao • Independent Non-executive Directors: Ms. Huang Yi Fei (Vanessa), Dr. Shao Rong and Ms. Wu May Yihong

Committee composition is as follows:

Audit Committee • Chair: Ms. Wu May Yihong • Members: Ms. Huang Jiaojiao, Ms. Huang Yi Fei (Vanessa), Dr. Shao Rong

Nomination Committee • Chair: Mr. Shen Difan • Members: Dr. Shao Rong, Ms. Wu May Yihong

Remuneration Committee • Chair: Ms. Huang Yi Fei (Vanessa) • Member: Ms. Wu May Yihong

The announcement confirms that all appointments are effective immediately from the stated date, strengthening oversight across audit, nomination and remuneration matters. No additional governance or operational changes were disclosed in the document.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187554747?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-29 17:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187554747","market":"us","top_or_hot":-1,"title":"ALI HEALTH Reveals New Board Line-up and Committee Leadership Effective 29 July 2026","media":"Bulletin Express","content":"<p>ALI HEALTH (Alibaba Health Information Technology Limited) released an update on its corporate governance structure, confirming board and committee appointments that take effect on 29 July 2026.</p>\n<p>The reconstituted Board will comprise six members:\n• Executive Directors: Mr. Shen Difan (Chairman and Chief Executive Officer) and Ms. Sheng Mengyue  \n• Non-executive Director: Ms. Huang Jiaojiao  \n• Independent Non-executive Directors: Ms. Huang Yi Fei (Vanessa), Dr. Shao Rong and Ms. Wu May Yihong</p>\n<p>Committee composition is as follows:</p>\n<p>Audit Committee  \n• Chair: Ms. Wu May Yihong  \n• Members: Ms. Huang Jiaojiao, Ms. Huang Yi Fei (Vanessa), Dr. Shao Rong</p>\n<p>Nomination Committee  \n• Chair: Mr. Shen Difan  \n• Members: Dr. Shao Rong, Ms. Wu May Yihong</p>\n<p>Remuneration Committee  \n• Chair: Ms. Huang Yi Fei (Vanessa)  \n• Member: Ms. Wu May Yihong</p>\n<p>The announcement confirms that all appointments are effective immediately from the stated date, strengthening oversight across audit, nomination and remuneration matters. No additional governance or operational changes were disclosed in the document.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ALI HEALTH Reveals New Board Line-up and Committee Leadership Effective 29 July 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nALI HEALTH Reveals New Board Line-up and Committee Leadership Effective 29 July 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-29 17:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ALI HEALTH (Alibaba Health Information Technology Limited) released an update on its corporate governance structure, confirming board and committee appointments that take effect on 29 July 2026.</p>\n<p>The reconstituted Board will comprise six members:\n• Executive Directors: Mr. Shen Difan (Chairman and Chief Executive Officer) and Ms. Sheng Mengyue  \n• Non-executive Director: Ms. Huang Jiaojiao  \n• Independent Non-executive Directors: Ms. Huang Yi Fei (Vanessa), Dr. Shao Rong and Ms. Wu May Yihong</p>\n<p>Committee composition is as follows:</p>\n<p>Audit Committee  \n• Chair: Ms. Wu May Yihong  \n• Members: Ms. Huang Jiaojiao, Ms. Huang Yi Fei (Vanessa), Dr. Shao Rong</p>\n<p>Nomination Committee  \n• Chair: Mr. Shen Difan  \n• Members: Dr. Shao Rong, Ms. Wu May Yihong</p>\n<p>Remuneration Committee  \n• Chair: Ms. Huang Yi Fei (Vanessa)  \n• Member: Ms. Wu May Yihong</p>\n<p>The announcement confirms that all appointments are effective immediately from the stated date, strengthening oversight across audit, nomination and remuneration matters. No additional governance or operational changes were disclosed in the document.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00241","symbol_name":"阿里健康","start_time":0,"source_url":"","article_id":"1187554747","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187554747","pubTimestamp":1785317120,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"ALI HEALTH (Alibaba Health Information Technology Limited) released an update on its corporate governance structure, confirming board and committee appointments that take effect on 29 July 2026. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00241":"阿里健康"},"translate_title":"阿里健康公布新的董事会阵容和委员会领导层，将于2026年7月29日生效","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00241":1},"content_text":"ALI HEALTH (Alibaba Health Information Technology Limited) released an update on its corporate governance structure, confirming board and committee appointments that take effect on 29 July 2026.\nThe reconstituted Board will comprise six members:\n• Executive Directors: Mr. Shen Difan (Chairman and Chief Executive Officer) and Ms. Sheng Mengyue  \n• Non-executive Director: Ms. Huang Jiaojiao  \n• Independent Non-executive Directors: Ms. Huang Yi Fei (Vanessa), Dr. Shao Rong and Ms. Wu May Yihong\nCommittee composition is as follows:\nAudit Committee  \n• Chair: Ms. Wu May Yihong  \n• Members: Ms. Huang Jiaojiao, Ms. Huang Yi Fei (Vanessa), Dr. Shao Rong\nNomination Committee  \n• Chair: Mr. Shen Difan  \n• Members: Dr. Shao Rong, Ms. Wu May Yihong\nRemuneration Committee  \n• Chair: Ms. Huang Yi Fei (Vanessa)  \n• Member: Ms. Wu May Yihong\nThe announcement confirms that all appointments are effective immediately from the stated date, strengthening oversight across audit, nomination and remuneration matters. No additional governance or operational changes were disclosed in the document.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187554747","isCrawlerRequest":true}